参考文献/References:
[1] KAPELIOS C J, SHAHIM B, LUND L H, et al. Epide-miology, clinical characteristics and cause-specific out-comes in heart failure with preserved ejection fraction [J]. Cardiac Failure Review, 2023, 9: e14.
[2] 廖玉华,杨杰孚,张健,等.舒张性心力衰竭诊断和治疗专家共识[J].临床心血管病杂志,2020,36(1):1-10. LIAO Y H, YANG J F, ZHANG J, et al. An expert con-sensus for diagnosis and treatment of diastolic heart fail-ure[J]. Journal of Clinical Cardiology, 2020, 36(1): 1-10.
[3] GOKHALE T A, DHANDE M, MULUKUTLA S, et al. Severity of diastolic dysfunction predicts myocardial in-farction [J]. IJC Heart & Vasculature, 2024, 55: 101532.
[4] GORICA E, GEIGER M A, DI VENANZIO L, et al. Cardiometabolic heart failure with preserved ejection fraction: from molecular signatures to personalized treat-ment[J]. Cardiovascular Diabetology, 2025, 24(1): 265.
[5] 包秋红,贾海玉,张勇,等.射血分数保留性心力衰竭患者血清miR-146a, IRAK-1表达水平与血管内皮功能、心室重构的相关性分析[J].现代检验医学杂志, 2023, 38(3): 109-113, 127. BAO Q H, JIA H Y, ZHANG Y, et al. Correlation analysis of serum miR-146a, IRAK-1 expression lev-els with vascular endothelial function and ventricular remodeling in patients with ejection fraction preserved heart failure[J]. Journal of Modern Laboratory Medi-cine, 2023, 38(3): 109-113, 127.
[6] BORLAUG B A, JENSEN M D, KITZMAN D W, et al. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets[J]. Cardiovascular Research, 2023, 118(18): 3434-3450.
[7] 王敏敏,张丽霞,淡一航,等.心血管疾病与胰岛素抵抗相关性机制及其与三酰甘油葡萄糖指数关系的研究进展[J].中华老年心脑血管病杂志, 2025, 27(8):1114-1117. WANG M M, ZHANG L X, DAN Y H, et al. Research prog-ress on the correlation mechanism between cardiovascular disease and insulin resistance and its relationship with the triglyceride-glucose index[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases, 2025, 27(8): 1114-1117.
[8] MCDONAGH T A, METRA M, ADAMO M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. European Journal of Heart Failure, 2022, 24(1): 3599-3726.
[9] UPADHYA B, KITZMAN D W. Heart failure with pre-served ejection fraction: new approaches to diagnosis and management[J]. Clinical Cardiology, 2020, 43(2): 145-155.
[10] WENZEL J P, KELLEN R B D, MAGNUSSEN C, et al. Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction[J]. Clinical Research in Cardiology, 2022, 111(4): 416-427.
[11] DADON Z, MORIEL M, TIRHI A, et al. Prevalence and long-term prognostic significance of advanced diastolic dysfunction among hospitalized patients referred for echo-cardiography[J]. Journal of Clinical Medicine, 14(4): 1096.
[12] BANSAL S, BURMAN A, TRIPATHI A K. Advanced glycation end products: key mediator and therapeutic target of cardiovascular complications in diabetes[J].World Journal of Diabetes, 2023, 14(8): 1146-1162.
[13] SUN J H, ZHOU R L, LIU M, et al. The role of myo-cardial fibrosis in the diabetic cardiomyopathy[J]. Dia-betology & Metabolic Syndrome, 2025, 17(1): 242.
[14] LI Z M, HAN D, QI T F, et al. Hemoglobin A1c in type 2 diabetes mellitus patients with preserved ejection fraction is an independent predictor of left ventricular myocardial deformation and tissue abnormalities[J]. BMC Cardiovascular Disorders, 2023, 23(1): 49.
[15] KIM S E, YOO B S. Obesity and heart failure with pre-served ejection fraction: focus on new drugs and future direction in medical treatment [J]. The Korean Journal of Internal Medicine, 2025, 40(3): 357-370..
[16] 文亮,李洁,张敏霞,等.MIF介导ox-LDL对内皮细胞功能的影响及作用机制[J].心脏杂志, 2023, 35(6): 629-636. WEN L, LI J, ZHANG M X, et al. Macrophage migration inhibitory factor mediated effect of oxidized low density lipoprotein on endothelial cell function and its mecha-nism[J]. Chinese Heart Journal, 2023, 35(6): 629-636.
[17] ZHOU Q, YANG J, TANG H Y, et al. High triglycer-ide-glucose (TyG) index is associated with poor prog-nosis of heart failure with preserved ejection fraction[J]. Cardiovascular Diabetology, 2023, 22(1): 263.
[18] 雷琳,王刚,赵鑫扬,等.TyG指数联合HbA1c对2型糖尿病老年患者左心室收缩功能障碍的预测价值[J].中国临床医学影像杂志, 2024, 35(3): 169-173. LEI L, WANG G, ZHAO X Y, et al. Predictive value of TyG index combined with HbA1c for left ventricu-lar systolic dysfunction in elderly patients with type 2 diabetes mellitus[J]. Journal of China Clinic Medical Imaging, 2024, 35(3): 169-173.
[19] XU L L, WU M Y, CHEN S H, et al. Triglyceride-glu-cose index associates with incident heart failure: a cohort study[J]. Diabetes & Metabolism, 2022, 48(6): 101365.
[20] 尤丽,迟昕萍,周雅琳,等.甘油三酯-葡萄糖指数与脑卒中发病风险关系的剂量-反应meta分析[J].中国循环杂志, 2025, 40(6): 611-618. YOU L, CHI X P, ZHOU Y L, et al. A dose-response me-ta-analysis between triglyceride-glucose index and risk of stroke[J]. Chinese Circulation Journal, 2025, 40(6): 611-618.
[21] LI Z, FAN X, LIU Y J, et al. Triglyceride-glucose index is associated with heart failure with preserved ejection fraction in different metabolic states in patients with coronary heart disease [J]. Frontiers in Endocrinology, 2024, 15: 1447072.
[22] 张颖, 唐以俊, 刘力滴, 等. 中国肥胖儿童青少年心血管代谢风险管理:基于2024年意大利儿科内分泌学和糖尿病学会《肥胖儿童和青少年的心血管代谢风险》立场文件[J]. 中国全科医学, 2025.10.12114/j.issn.1007-9572.2025.0118. ZHANG Y, TANG Y J, LIU L D, et al. Management of cardiovascular metabolic risks in obese children and adolescents in China: based on the 2024 Italian Society of Pediatric Endocrinology and Diabetes position paper on cardiovascular metabolic risk in obese children and adolescents[J]. Chinese General Practice, 2025.10.12114/j.issn.1007-9572.2025.0118.